HSP90AA1 and neoplasm: This study provides preliminary experimental evidence of sciadopitysin against glioblastoma to some extent; However, further research is needed to provide more experimental verifications including HSP90α and AKT1 downstream signaling cascades and animal experiments to explore in vivo anti-tumor effects of sciadopitysin.